BlackRock’s Timber Pharmaceuticals, Inc. TMBR Stock Holding History

BlackRock’s Portfolio TMBR Stock Details TMBR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Hold	0	–	–	–	5959
2022 Q3	–	Hold	0	–	–	–	5986
2022 Q2	–	Sell	-2,378	Closed	-$34.7K	–	6061
2022 Q1	$46K	Buy	2,378 +762	+47%	+$12.7K	﹤0.01%	5428
2021 Q4	$31K	Buy	1,616 +42	+3%	+$1.19K	﹤0.01%	5491
2021 Q3	$71K	Sell	1,574 -302	-16%	-$14.8K	﹤0.01%	5231
2021 Q2	$114K	Buy	+1,876	New	+$132K	﹤0.01%	5013
2021 Q1	–	Hold	0	–	–	–	5391
2020 Q4	–	Hold	0	–	–	–	5216
2020 Q3	–	Hold	0	–	–	–	5202
2020 Q2	–	Hold	0	–	–	–	5181
2020 Q1	–	Hold	0	–	–	–	5122
2019 Q4	–	Hold	0	–	–	–	5112
2019 Q3	–	Hold	0	–	–	–	5115
2019 Q2	–	Hold	0	–	–	–	5119
2019 Q1	–	Hold	0	–	–	–	4908
2018 Q4	–	Hold	0	–	–	–	4931
2018 Q3	–	Hold	0	–	–	–	4980
2018 Q2	–	Hold	0	–	–	–	4993
2018 Q1	–	Hold	0	–	–	–	4902
2017 Q4	–	Hold	0	–	–	–	5033
2017 Q3	–	Hold	0	–	–	–	4940
2017 Q2	–	Hold	0	–	–	–	4924
2017 Q1	–	Hold	0	–	–	–	4910

Other funds holding TMBR

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return

CPG

Cornerstone Planning Group Fairfield, New Jersey $749M AUM 17.97% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

PNC Financial Services Group Pittsburgh, Pennsylvania $173B AUM 20.72% 1-Year Est. Return

BlackRock's TMBR Position: Q4 2022 in Review

BlackRock held its Timber Pharmaceuticals, Inc. (TMBR) position steady in Q4 2022 at 0 shares worth $0. The position accounts for ﹤0.01% of the portfolio, ranked #5959.

BlackRock first reported a position in TMBR in Q2 2021 and has held it in 4 quarters since. The position peaked at $114K in Q2 2021. 11 funds tracked by Wall St. Rank hold TMBR as of Q4 2022.

BlackRock held 0 shares of Timber Pharmaceuticals, Inc. worth $0 as of Q4 2022.
BlackRock left its Timber Pharmaceuticals, Inc. share count unchanged in Q4 2022.
Timber Pharmaceuticals, Inc. made up ﹤0.01% of BlackRock's portfolio in Q4 2022, its #5959 holding.
BlackRock first reported a position in Timber Pharmaceuticals, Inc. in Q2 2021 and has held it in 4 quarters since.
BlackRock's Timber Pharmaceuticals, Inc. position peaked at $114K in Q2 2021.
11 funds tracked by Wall St. Rank held Timber Pharmaceuticals, Inc. as of Q4 2022.

Based on BlackRock's 13F filing for Q4 2022, filed 13 Feb 2023.